October 25,2010
Grassley Asks FDA about Medical Device Company Payments to Doctors in Clinical Studies
WASHINGTON – On Friday, Sen. Chuck Grassley of Iowa asked the Food and Drug Administration how the agency handles reports of medical device companies' payments to doctors who are participating in clinical studies of the companies' products.
Grassley wrote to the FDA commissioner, citing information that doctors participating in clinical trials sponsored by a particular medical device maker also received significant payments from that device maker.
“The FDA should be transparent and describe what it does with information about potential conflicts of interest, including any steps it takes to protect the integrity and reliability of clinical research,” Grassley said.
Next Article Previous Article
Recent News
- As Trump Sits on Key Epstein Files, Wyden Lays Out “Follow the Money” Investigation for DOJ
- Across the Country, Health Insurance Premiums Set to Spike Thanks to Trumpcare
- Wyden Statement on HHS and Treasury Department Nominees at Finance Committee Hearing
- Ahead of committee vote, Wyden opposes Treasury and USTR nominees
- Bipartisan Delegation Urges De-Escalation of US-Canada Trade Conflict In Meeting with Canadian Prime Minister Carney